Renee Maria Saliby

⭐️Over the moon to have matched at @YaleIMed I cannot wait to experience and hopefully live up to: "As good as any, nicer than most" @MarkDSiegel1 (I can finally use this GIF! hope I do better than Rory!)

Many congratulations Berkay Simsek for being a recipient of the KCRS 2025 Merit Awards for Translational Research @simsek_berkay_ @kidneycan @MassGenBrigham #KCRS25 #kidneycancer

And that is wrap for #KCRS2025 @HHammersMD @advocatekidneys @kidneycan

🚨Internal medicine applicant @MarcMachaalani presents the work on KIM-1 like a pro⭐️ KIM-1 is a promising biomarker as well as a great reflection of broader tumor biology #KCRS25 @OncoAlert

Updated KEYNOTE-B61 data with a 50% ORR and durable responses in patient with variant histology RCC A lot of hope for 1st line therapy in that setting and a wonderful talk by @AlbigesL #KCRS25 @OncoAlert

What a panel for Oral Presentation session! Starting with a phenomenal presentation by @DrChoueiri on combininh cabo+casdatifan (ARC-20) with new trials being announced @OncoAlert #KCRS25

Surreal to finally be applying this cycle for hematology oncology fellowship, with a focus on classical heme- it’s been a dream that started as a med student & has only strengthened as I made my way through a postdoc in classical heme @YaleCancer and then residency @TradIMYale…

Takeaways from @VincentWenxinXu 's majestic talk on biomarkers: - Several biomarkers have been studied in RCC - Current biomarkers in RCC do not correspond to patient's goals - The future is in integrative biomarkers - Let's get back to work to answer all the different questions…

Now onto rare subtypes with a great overview of ongoing clinical work in the space by @bilenma We've made a lot of progress but still need to do better! @OncoAlert #KCRS25

The sunrise over Boston set the stage for an unforgettable Rock the Run. KCRS attendees ran, walked, and cheered in support of #KidneyCancer research, and the energy was unbeatable. Huge thanks to everyone who showed up early, wore their shirts proudly, and made this community…

💡 Great review of progress over the last 10 years in 1st-line metastatic RCC 🚀 and a call from David McDermott to work together to cure more patients with kidney cancer 🤝 @kidneycan #KCRS25 #rcc #kidneycancer

Clinical and scientific updates in RCC Kicking off day 2 of #KCRS25 with all you need to know if you've been living on the moon for the last year Inspirational first talk by Dr. McDermott setting the tone for the years to come @OncoAlert

Congratulations to @BraunMDPhD + @sidichen for being named Clinical Laboratory Integration Program (CLIP) awardees by @CancerResearch! CLIP supports early-phase studies that test the translational potential of new immunotherapy approaches. medicine.yale.edu/news-article/d… @SmilowCancer…

🌟Happening now at #KCRS25!! Great talk by @kor_shah on exploring health-related quality of life across the RCC spectrum through a conceptual domain analysis #kidneycancer👇 @kidneycan @OncoAlert @urotoday

Terrific presentation by @tompowles1 - impeccable as always The Q-TWiST analysis of belzutifan vs everolimus brings meaningful insights into quality-adjusted outcomes in RCC. A masterclass in clinically relevant data interpretation #KCRS25

Microbiome expert @CarolinaAlvesC5 elegantly presentsthe data on MAdCAM-1 in association with outcomes to IO-based therapies Circulating MadCAM-1 is a promising baseline and dynamic biomarker I love our 💩team! @MarcMachaalani #KCRS25 @OncoAlert

Can we restore NK cell anti-tumor activity against RCC? Stay tuned to follow the results of this first in human pilot study! @VincentWenxinXu #KCRS25 @OncoAlert